Company news

Chengdu Kanghong Pharmaceutical Group Co., Ltd. news

Latest news releases, newest first.

Chengdu Kanghong Pharmaceutical Q1 Net Profit Down 23.1% Y/Y

April 22, 2026

Chengdu Kanghong: US FDA Approves KHN921 Clinical Trial For Hypertrophic Cardiomyopathy Treatment

April 19, 2026